17-11598537-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001372.4(DNAH9):āc.39G>Cā(p.Glu13Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000286 in 1,406,996 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001372.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH9 | NM_001372.4 | c.39G>C | p.Glu13Asp | missense_variant | 1/69 | ENST00000262442.9 | NP_001363.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH9 | ENST00000262442.9 | c.39G>C | p.Glu13Asp | missense_variant | 1/69 | 1 | NM_001372.4 | ENSP00000262442 | P1 | |
DNAH9 | ENST00000579406.1 | n.66G>C | non_coding_transcript_exon_variant | 1/8 | 1 | |||||
DNAH9 | ENST00000454412.6 | c.39G>C | p.Glu13Asp | missense_variant | 1/68 | 5 | ENSP00000414874 | |||
DNAH9 | ENST00000579828.5 | c.39G>C | p.Glu13Asp | missense_variant | 1/4 | 2 | ENSP00000463782 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000271 AC: 8AN: 29540Hom.: 0 AF XY: 0.000350 AC XY: 6AN XY: 17164
GnomAD4 exome AF: 0.000291 AC: 365AN: 1254742Hom.: 1 Cov.: 33 AF XY: 0.000339 AC XY: 208AN XY: 612842
GnomAD4 genome AF: 0.000243 AC: 37AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74448
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 19, 2022 | The c.39G>C (p.E13D) alteration is located in exon 1 (coding exon 1) of the DNAH9 gene. This alteration results from a G to C substitution at nucleotide position 39, causing the glutamic acid (E) at amino acid position 13 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 12, 2022 | This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 13 of the DNAH9 protein (p.Glu13Asp). This variant is present in population databases (rs186019513, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with DNAH9-related conditions. ClinVar contains an entry for this variant (Variation ID: 1464229). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The aspartic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Ciliary dyskinesia, primary, 40 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 11, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at